X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (325) 325
Publication (29) 29
Patent (17) 17
Book Chapter (5) 5
Conference Proceeding (5) 5
Book Review (2) 2
Book / eBook (1) 1
Journal / eJournal (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (143) 143
index medicus (87) 87
female (86) 86
male (74) 74
immunohistochemistry (69) 69
middle aged (63) 63
adult (61) 61
oncology (60) 60
pathology (60) 60
aged (55) 55
cancer (54) 54
tumors (44) 44
mutation (36) 36
aged, 80 and over (30) 30
breast cancer (29) 29
genetic aspects (26) 26
expression (25) 25
diagnosis (22) 22
gene expression (22) 22
carcinoma (21) 21
research (21) 21
adolescent (20) 20
analysis (20) 20
breast neoplasms - genetics (20) 20
surgery (19) 19
care and treatment (18) 18
genetics & heredity (18) 18
in situ hybridization, fluorescence (18) 18
development and progression (17) 17
investigating or analysing materials by determining theirchemical or physical properties (17) 17
measuring (17) 17
physics (17) 17
testing (17) 17
article (16) 16
chemotherapy (16) 16
mutations (16) 16
targeted therapy (16) 16
young adult (16) 16
breast neoplasms - metabolism (15) 15
breast neoplasms - pathology (15) 15
gene expression regulation, neoplastic (15) 15
identification (15) 15
kidney neoplasms - pathology (15) 15
molecular profiling (15) 15
prognosis (15) 15
biomarkers (14) 14
chemistry (14) 14
proteins (14) 14
biochemistry (13) 13
biomarkers, tumor - metabolism (13) 13
cell biology (13) 13
child (13) 13
enzymology (13) 13
gene (13) 13
gene amplification (13) 13
microsatellite instability (13) 13
beer (12) 12
compositions or test papers therefor (12) 12
condition-responsive control in microbiological orenzymological processes (12) 12
general tagging of cross-sectional technologies spanning over several sections of the ipc (12) 12
general tagging of new technological developments (12) 12
genes (12) 12
genetics (12) 12
kidney neoplasms - genetics (12) 12
measuring or testing processes involving enzymes, nucleicacids or microorganisms (12) 12
medical laboratory technology (12) 12
metallurgy (12) 12
microbiology (12) 12
mutation or genetic engineering (12) 12
processes of preparing such compositions (12) 12
spirits (12) 12
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (12) 12
technologies for adaptation to climate change (12) 12
technologies or applications for mitigation or adaptation againstclimate change (12) 12
vinegar (12) 12
wine (12) 12
biomarkers, tumor - analysis (11) 11
biomarkers, tumor - genetics (11) 11
carcinoma, renal cell - pathology (11) 11
cell lung-cancer (11) 11
diagnosis, differential (11) 11
gene expression profiling (11) 11
kidney (11) 11
medicine, research & experimental (11) 11
metastasis (11) 11
neoplasms (11) 11
androgen receptor (10) 10
breast (10) 10
colorectal cancer (10) 10
estrogen (10) 10
gene mutations (10) 10
high-throughput nucleotide sequencing (10) 10
polymerase chain reaction (10) 10
protein (10) 10
adenocarcinoma (9) 9
adenoid cystic carcinoma (9) 9
amplification (9) 9
association (9) 9
cells (9) 9
cytogenetics (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Modern Pathology, ISSN 0893-3952, 01/2019, Volume 32, Issue 1, pp. 147 - 153
Targeted inhibitors of neurotropic tyrosine kinases are highly effective in selected patients with gene fusions involving NTRK1, NTRK2, or NTRK3. These fusions... 
PAN-TRK | ENTRECTINIB | INFANTILE FIBROSARCOMA | PATIENT | PATHOLOGY | ALK INHIBITOR | REARRANGEMENTS | CLINICAL-RESPONSE | ROS1 | CARCINOMA | IMMUNOHISTOCHEMISTRY | Tyrosine | Immunohistochemistry | Genes | Fibrosarcoma | Microsatellite instability | Gene fusion | Thyroid carcinoma | Breast carcinoma | Immune checkpoint | Colon cancer | Glioma | Nose | PD-L1 protein | TrkA protein | TrkA receptors | Colon | Cervical cancer | Movement disorders | Thyroid
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 4605 - 4605
Journal Article
Original Article - FISH for HER-2/neu in breast cancer: Standardization makes the difference, 10/2004
CONTEXT: Overexpression of HER-2/neu oncogene in breast cancer patients is correlated with disease free survival (DFS) and overall survival (OS). The most... 
Breast cancer, HER-2/neu, Amplification, IHC, FISH, DCIS, Pathvysion™, Validation. cn04029 | Botany
Journal
Journal Article
European Journal of Cancer, ISSN 0959-8049, 05/2018, Volume 94, pp. 179 - 186
Cancer of unknown primary (CUP) accounts for approximately 3% of all malignancies. Avoiding immune destruction is a major cancer characteristic and therapies... 
Targeted therapy | Cancer of unknown primary (CUP) | Immune checkpoint inhibitors | DIAGNOSIS | MULTICENTER | PD-1 BLOCKADE | METASTATIC UROTHELIAL CARCINOMA | OPEN-LABEL | DOCETAXEL | PEMBROLIZUMAB | ONCOLOGY | PREDICTIVE BIOMARKERS | NIVOLUMAB MONOTHERAPY | INHIBITOR | Immunohistochemistry | Immune response | Gene mutations | Analysis | Tumor proteins | Biological markers | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2018, Volume 13, Issue 1, p. e0191244
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, p. e0166266
Targeted immunotherapy based on PD-1/PD-L1 suppression has revolutionized the treatment of various solid tumors. A remarkable improvement has also been... 
ANTIBODIES | PDL1 EXPRESSION | AMPLIFICATION | MULTIDISCIPLINARY SCIENCES | B-CELL LYMPHOMAS | HODGKIN LYMPHOMA | JAK2 | Immunohistochemistry | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Biomarkers, Tumor | DNA Copy Number Variations | Lymphoma - metabolism | Young Adult | Lymphoma - drug therapy | Janus Kinase 2 - metabolism | Aged, 80 and over | Adult | Female | Gene Expression | Lymphoma - diagnosis | Janus Kinase 2 - genetics | Lymphoma - genetics | Programmed Cell Death 1 Receptor - metabolism | In Situ Hybridization, Fluorescence | B7-H1 Antigen - genetics | B7-H1 Antigen - metabolism | Adolescent | Aged | High-Throughput Nucleotide Sequencing | Programmed Cell Death 1 Receptor - genetics | Viral antibodies | Medical research | Care and treatment | Analysis | Medicine, Experimental | Antibodies | Non-Hodgkin's lymphomas | T cells | Cancer | PD-1 protein | Laboratories | Copy number | Lung cancer | Fluorescence | Lymphocytes T | Assaying | Proteins | Immunotherapy | Janus kinase 2 | Life sciences | Immunoglobulins | Automation | Chronic lymphatic leukemia | Cloning | Breast cancer | Gene expression | Patients | Lymphoma | Amplification | Gene amplification | Lymphocytes B | PD-L1 protein | Biomarkers | Protein expression | Ligands | Lymphomas | Solid tumors | Hodgkin's disease | Tumors | B-cell lymphoma
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 05/2018, Volume 94, p. 179
Background Cancer of unknown primary (CUP) accounts for approximately 3% of all malignancies. Avoiding immune destruction is a major cancer characteristic and... 
Immunohistochemistry | MDM2 protein | Microsatellites | Stability | p53 Protein | Genes | Microsatellite instability | Medical diagnosis | Gene sequencing | Adenomatous polyposis coli | Amplification | Gene amplification | Immune checkpoint | Janus kinase 2 | PD-L1 protein | Biomarkers | Mutation | Targeted cancer therapy | Deoxyribonucleic acid--DNA | Immune system | Tumors | DNA sequencing | Cancer
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 1757 - 1757
Journal Article
Human Pathology, ISSN 0046-8177, 2015, Volume 46, Issue 9, pp. 1350 - 1359
Summary Despite the marked improvement in the understanding of molecular mechanisms and classification of apocrine carcinoma, little is known about its... 
Pathology | Immunohistochemistry | Fluorescent in situ hybridization | Breast carcinoma–apocrine carcinoma | Next-generation sequencing | Multiplex ligation-dependent probe amplification | Androgen receptor | Breast carcinoma-apocrine carcinoma | AMPLICON | CLINICAL ONCOLOGY/COLLEGE | PATHOLOGY | CANCER | TUMORS | HETEROZYGOSITY | MESSENGER-RNA | RECOMMENDATIONS | ESTROGEN | EXPRESSION | AMERICAN SOCIETY | Predictive Value of Tests | Humans | Gene Expression Regulation, Neoplastic | Apocrine Glands - chemistry | Sweat Gland Neoplasms - pathology | Carcinoma - chemistry | Breast Neoplasms - chemistry | Molecular Diagnostic Techniques | Female | Carcinoma - pathology | Sweat Gland Neoplasms - chemistry | Apocrine Glands - pathology | Genetic Predisposition to Disease | Sweat Gland Neoplasms - diagnosis | Biomarkers, Tumor - analysis | Carcinoma - diagnosis | In Situ Hybridization, Fluorescence | Multiplex Polymerase Chain Reaction | Sweat Gland Neoplasms - genetics | Phenotype | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Carcinoma - genetics | Biomarkers, Tumor - genetics | Breast Neoplasms - diagnosis | High-Throughput Nucleotide Sequencing | Cluster Analysis | Cytogenetics | Breast cancer | Tumor proteins | Analysis | Morphology | Gangrene | Software | Mutation | Hybridization | Deoxyribonucleic acid--DNA | Tumors
Journal Article